Current progress in the gene therapy of cancer.

Abstract:

:Gene transfer for the treatment of cancer is a rapidly expanding field. Recent studies can be divided into four main areas: 1) transfer of suicide genes that convert inactive prodrugs into cytotoxic compounds, 2) transfer of genes encoding cytokines and stimulatory markers to enhance immunogenicity against tumors, 3) transfer of tumor-suppressor genes to block tumor cell proliferation, and 4) transfer of drug resistance genes into hematopoietic stem cells to increase their resistance to myelo-suppressive chemotherapeutic agents. This review discusses recent advances in technique and knowledge and their application to the gene therapy of cancer.

journal_name

Curr Opin Oncol

authors

Davis BM,Koc ON,Lee K,Gerson SL

doi

10.1097/00001622-199611000-00010

subject

Has Abstract

pub_date

1996-11-01 00:00:00

pages

499-508

issue

6

eissn

1040-8746

issn

1531-703X

journal_volume

8

pub_type

杂志文章,评审
  • Recent advances in telomere biology: implications for human cancer.

    abstract:PURPOSE OF REVIEW:Research into the basic biology of telomeres continues to reveal details relevant to fundamental aspects of human cancer. The goal of this review is to highlight discoveries made within the last year, with emphasis on their relevance to cancer prevention, diagnosis, prognostics, and treatment. RECENT...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/00001622-200401000-00007

    authors: Meeker AK,De Marzo AM

    更新日期:2004-01-01 00:00:00

  • Advances in the treatment of elderly and frail patients with acute myeloid leukemia.

    abstract:PURPOSE OF REVIEW:Significant advances have been made in the treatment of younger patients with acute myeloid leukemia over the past 3 decades, but prognosis in the elderly has remained dismal, with median survival times of only a few months. Although a small percentage of older patients may be cured by standard chemot...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/CCO.0000000000000124

    authors: Amadori S,Del Principe MI,Venditti A

    更新日期:2014-11-01 00:00:00

  • Osteosarcoma and other bone cancers.

    abstract::In this review, recent advances in the clinical therapy of osteosarcoma, including results from the European Osteosarcoma Intergroup trial demonstrating the efficacy of a short intensive two drug protocol are discussed as well the evolving role of ifosfamide. Biologically, the area of interest on chromosome 3q, which ...

    journal_title:Current opinion in oncology

    pub_type: 临床试验,杂志文章,评审

    doi:10.1097/00001622-199807000-00009

    authors: Himelstein BP

    更新日期:1998-07-01 00:00:00

  • Late sequelae of treatment of Hodgkin's disease.

    abstract::Twenty-three years after it was observed that successful treatment of Hodgkin's disease was associated with risk of a second malignancy related to treatment, the literature is maturing. Early reports of leukemia risk rising and falling between 5 and 10 years after treatment continue to be supported. The real problem i...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章

    doi:10.1097/00001622-199709050-00006

    authors: DeVita VT Jr

    更新日期:1997-09-01 00:00:00

  • Systemic therapy.

    abstract::New data continue to refine our knowledge of systemic therapy for breast cancer. These include the third Oxford Overview on adjuvant systemic therapy, a small advantage of anthracycline regimens over CMF (cyclophosphamide, methotrexate, and 5-fluorouracil), and renewed interest in the "classic CMF" regimen. Primary ch...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/00001622-199911000-00007

    authors: Wolff AC

    更新日期:1999-11-01 00:00:00

  • The next-generation ALK inhibitors.

    abstract:PURPOSE OF REVIEW:Crizotinib now is accepted as the standard first-line treatment of ALK-rearranged lung adenocarcinomas. To overcome the problem of crizotinib resistance, second-generation ALK inhibitors are in development. The aim of this review is to give an overview on the mechanisms behind crizotinib resistance an...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/CCO.0000000000000165

    authors: Pall G

    更新日期:2015-03-01 00:00:00

  • Vandetanib and the management of advanced medullary thyroid cancer.

    abstract:PURPOSE OF REVIEW:Vandetanib is a small molecule tyrosine kinase inhibitor that has been recently approved as an 'orphan drug' for the treatment of patients with unresectable, locally advanced, or metastatic medullary thyroid cancer (MTC). RECENT FINDINGS:MTC is a neuroendocrine malignancy frequently associated with m...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/CCO.0b013e32835a42b9

    authors: Campbell MJ,Seib CD,Gosnell J

    更新日期:2013-01-01 00:00:00

  • Palliative care in glioma management.

    abstract:PURPOSE OF REVIEW:The concept of palliative care is becoming increasingly important in the management of glioma patients. However, the right time for implementation, as well as the individual degree of integration of palliative care aspects, are still a matter of debate. This review updates recent evidence of palliativ...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/CCO.0000000000000584

    authors: Oberndorfer S,Hutterer M

    更新日期:2019-11-01 00:00:00

  • Three molecular determinants of malignant conversion and their potential as therapeutic targets.

    abstract::The past decade has been marked by an explosion of knowledge regarding the dysregulation of cancer at the molecular level. It has become apparent that oncogenes, tumor suppressor genes, and other ancillary molecules interact in complex pathways that govern cellular homeostasis. We review three molecular events that ha...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/00001622-199901000-00013

    authors: Dome JS,Look AT

    更新日期:1999-01-01 00:00:00

  • Mitogen-activating protein kinase pathway alterations in Langerhans cell histiocytosis.

    abstract:PURPOSE OF REVIEW:Langerhans cell histiocytosis (LCH) is a rare disorder characterized by the infiltration of involved tissues by specialized dendritic cells. The demonstration of the constant activation of the mitogen-activated protein kinase (MAPK) pathway in LCH lesions has been a breakthrough in the understanding o...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章

    doi:10.1097/CCO.0000000000000707

    authors: Jouenne F,Benattia A,Tazi A

    更新日期:2020-12-09 00:00:00

  • On mitochondrial metabolism in tumor biology.

    abstract:PURPOSE OF REVIEW:To provide examples of mitochondria-specific metabolic events that influence tumor cell biology, and of metabolism-related mitochondrial biomarkers and therapeutic targets in cancer cells. RECENT FINDINGS:Cancer cell mitochondria are rewired to optimally serve the cancer cell under various conditions...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/CCO.0000000000000336

    authors: Shoshan M

    更新日期:2017-01-01 00:00:00

  • Paracrine interactions of cancer-associated fibroblasts, macrophages and endothelial cells: tumor allies and foes.

    abstract:PURPOSE OF REVIEW:Tumor stroma is composed of many cellular subtypes, of which the most abundant are fibroblasts, macrophages and endothelial cells. During the process of tissue injury, these three cellular subtypes must coordinate their activity to efficiently contribute to tissue regeneration. In tumor, this mechanis...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/CCO.0000000000000420

    authors: Ronca R,Van Ginderachter JA,Turtoi A

    更新日期:2018-01-01 00:00:00

  • Testicular germ cell tumors.

    abstract:PURPOSE OF REVIEW:Preclinical and clinical developments in germ cell tumors over the past year are summarized. RECENT FINDINGS:Attenuations in the rising incidence of testicular germ cell tumors are beginning to be observed in certain European populations. Additional data on predisposing factors related to race, estro...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/CCO.0b013e3280ad43df

    authors: Bridges B,Hussain A

    更新日期:2007-05-01 00:00:00

  • Chronic graft-versus-host disease.

    abstract:PURPOSE OF REVIEW:Chronic graft-versus-host disease is an important cause of late morbidity and mortality after allogeneic stem cell transplantation. With the renewed interest in its pathophysiology and treatment, this review discusses recent clinical and laboratory advances in this disease. Advances in pathophysiology...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/01.cco.0000208784.07195.84

    authors: Cutler C,Antin JH

    更新日期:2006-03-01 00:00:00

  • Adenocarcinoma of the small bowel: changes in the landscape?

    abstract:PURPOSE OF REVIEW:Small bowel adenocarcinoma (SBA) is a rare cancer with a poor prognosis and little information to guide its management. In recent years, improved diagnostic imaging and an increase in reported experience with use of chemotherapy may alter the way we manage SBA. This review will summarize recent advanc...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/CCO.0b013e32833a86fe

    authors: Speranza G,Doroshow JH,Kummar S

    更新日期:2010-07-01 00:00:00

  • The type II transforming growth factor-beta receptor as a tumor-suppressor gene.

    abstract::Recent work has shown that: 1) loss of transforming growth factor-beta response is associated with malignant progression, 2) maintenance of autocrine negative transforming growth factor-beta activity is a key impediment to malignant progression, and 3) the major mechanism for loss of RII expression in replication erro...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/00001622-199601000-00009

    authors: Brattain MG,Markowitz SD,Willson JK

    更新日期:1996-01-01 00:00:00

  • Gene transfer technologies for malignant gliomas.

    abstract::Although early clinical gene therapy trials for recurrent central nervous system neoplasms showed the proof-of-principle, they did not fulfill the high expectations suggested by the preclinical experimental data. Insufficient distribution of vectors in human brain tumors and very low transduction efficiency require th...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/00001622-199905000-00005

    authors: Weyerbrock A,Oldfield EH

    更新日期:1999-05-01 00:00:00

  • Screening, staging, and diagnostic investigation of non-small cell lung cancer patients.

    abstract::Despite its appeal, lung cancer screening has been found to be of little value at this time. However, use of monoclonal antibodies to detect cancer cells in the sputum may prove to be of value in high-risk subjects. Once a cancer is diagnosed, anatomic staging by the International TNM Staging System has shown its effe...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/00001622-199104000-00010

    authors: Shields TW

    更新日期:1991-04-01 00:00:00

  • Should the indications for the use of myeloid growth factors for the prevention of febrile neutropenia in cancer patients be extended?

    abstract:PURPOSE OF REVIEW:Prevention of infectious complications of chemotherapy-induced granulocytopenia is a major issue in preventive medicine, as febrile neutropenia is still associated with an overall 10% mortality and extensive morbidity and cost. RECENT FINDINGS:The prescription of granulocyte colony-stimulating factor...

    journal_title:Current opinion in oncology

    pub_type: 社论,评审

    doi:10.1097/CCO.0b013e32832c9651

    authors: Klastersky J,Awada A,Aoun M,Paesmans M

    更新日期:2009-07-01 00:00:00

  • Molecule-targeted agents in endometrial cancer.

    abstract:PURPOSE OF REVIEW:Endometrial cancer is the most common gynaecological malignancy for which platinum-based and anthracycline-based combinations, with/without taxanes, are the most active but toxic treatments. The preliminary results achieved with two molecule-targeted agents suggest that a better knowledge in molecular...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/CCO.0b013e32830b0deb

    authors: Delmonte A,Sessa C

    更新日期:2008-09-01 00:00:00

  • Tumor microenvironment in mycosis fungoides and Sézary syndrome.

    abstract:PURPOSE OF REVIEW:Mycosis fungoides and Sézary syndrome arise from malignant T cells that reside in skin, and subsequently are capable of circulating between skin, lymph nodes, and blood. The pathophysiologic mechanisms that cause and result in different behaviors of the skin-homing-malignant T cells in different stage...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/CCO.0000000000000243

    authors: Rubio Gonzalez B,Zain J,Rosen ST,Querfeld C

    更新日期:2016-01-01 00:00:00

  • New developments in bone marrow transplantation.

    abstract::A better understanding of the immunobiology after transplantation and of the available recombinant cytokines that enhance hematopoietic reconstitution following autologous and allogeneic bone marrow transplantation is likely to result in safer application of bone marrow transplantation. Residual tumor cells escaping c...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/00001622-199104000-00005

    authors: Slavin S,Nagler A

    更新日期:1991-04-01 00:00:00

  • Rectal cancer: state of the art in 2012.

    abstract:PURPOSE OF REVIEW:To discuss the recent developments of multimodal treatment for patients with local advanced rectal cancer, including incorporation of new chemotherapeutic and targeted agents, and the optimal sequence and timing of treatment components. RECENT FINDINGS:Five randomized trials have been completed to de...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/CCO.0b013e328352ea02

    authors: Rödel C,Hofheinz R,Liersch T

    更新日期:2012-07-01 00:00:00

  • Serial analysis of gene expression and cancer.

    abstract::Serial analysis of gene expression has been widely used to characterize gene expression patterns associated with tumor formation. These studies resulted in the identification of tumor-specific markers, transcriptional pathways, or therapeutic targets. In this review, recent applications and developments of serial anal...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/00001622-200301000-00006

    authors: Hermeking H

    更新日期:2003-01-01 00:00:00

  • Immune-mediated respiratory adverse events of checkpoint inhibitors.

    abstract:PURPOSE OF REVIEW:Immune checkpoint inhibitors have demonstrated remarkable efficacy with durable responses in the treatment of various malignancies. This new class of therapeutic agents is associated with a toxicity profile that differs from conventional cytotoxic therapy. The present review is focused on one of these...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/CCO.0000000000000291

    authors: Tabchi S,Messier C,Blais N

    更新日期:2016-07-01 00:00:00

  • Tyrosine kinase inhibitors-ZD1839 (Iressa).

    abstract::Several epithelial tumors display epidermal growth factor receptor (EGFR) overexpression (with or without EGFR gene amplification) that is often associated with increased production of EGFR ligands. This permits the activation of endogenous tumor EGFR via autocrine mechanisms, resulting in cellular proliferation and t...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/00001622-200111000-00012

    authors: Arteaga CL,Johnson DH

    更新日期:2001-11-01 00:00:00

  • Bone marrow transplantation for chronic myelogenous leukemia.

    abstract::It is generally accepted that patients with chronic myelogenous leukemia in chronic phase under the age of 50 years who have HLA-identical siblings, should be offered bone marrow transplantation within the first year of diagnosis. The projected disease-free survival for these patients is 70% to 80% at 4 years, and mos...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/00001622-199204000-00004

    authors: Goldman JM

    更新日期:1992-04-01 00:00:00

  • Apply innovative technologies to explore cancer genome.

    abstract:PURPOSE OF REVIEW:Molecular genetic alterations characterize the development of human cancer. Recent advances in molecular genetic technology and the success of the human genome project have empowered investigators with new tools in dissecting the cancer genome for discovery of new cancer-associated genes. The purpose ...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/01.cco.0000147382.97085.e4

    authors: Shih IeM,Wang TL

    更新日期:2005-01-01 00:00:00

  • Class IA phosphoinositide 3-kinase isoforms and human tumorigenesis: implications for cancer drug discovery and development.

    abstract:PURPOSE OF REVIEW:The phosphoinositide 3-kinases are lipid kinases that are activated in response to external factors. They regulate a number of intracellular signaling pathways involved in cell motility, metabolism, survival, and growth. This review summarizes the current knowledge about specific contributions of Clas...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/CCO.0b013e3282f3111e

    authors: Wee S,Lengauer C,Wiederschain D

    更新日期:2008-01-01 00:00:00

  • Liquid biopsy for early detection of lung cancer.

    abstract:PURPOSE OF REVIEW:The possibility of complete recovery for a lung cancer patient depends on very early diagnosis, as it allows total surgical resection. Screening for this cancer in a high-risk population can be performed using a radiological approach, but this holds a certain number of limitations. Liquid biopsy could...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/CCO.0000000000000343

    authors: Hofman P

    更新日期:2017-01-01 00:00:00